A Multinational Investigation of the Impact of Subcutaneous Sumatriptan
- 1 January 1997
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 11 (1), 24-34
- https://doi.org/10.2165/00019053-199700111-00005
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Multinational Investigation of the Impact of Subcutaneous SumatriptanPharmacoEconomics, 1997
- A Multinational Investigation of the Impact of Subcutaneous SumatriptanPharmacoEconomics, 1997
- Impact of Sumatriptan on Workplace Productivity, Nonwork Activities, and Health‐Related Quality of Life Among Hospital Employees With MigraineHeadache: The Journal of Head and Face Pain, 1996
- Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.1996
- Quality of Life Assessment Among Migraine Patients Treated With SumatriptanHeadache: The Journal of Head and Face Pain, 1995
- Assessment of Health-Related Quality of Life in MigraineCephalalgia, 1993
- Sumatriptan Injection is Superior to Placebo in The Acute Treatment of Migraine With Regard to Both Efficacy and General Well-BeingCephalalgia, 1992
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.1992
- Treatment of Acute Migraine With Subcutaneous SumatriptanJama-Journal Of The American Medical Association, 1991
- Evaluation of a Multiple-Dose Regimen of Oral Sumatriptan for the Acute Treatment of MigraineEuropean Neurology, 1991